The Library
Possible role of oxidative stress in the pathogenesis of hypertension
Tools
Ceriello, Antonio (2008) Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care, Vol.31 (Suppl.2). S181-S184. doi:10.2337/dc08-s245 ISSN 0149-5992.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.2337/dc08-s245
Abstract
Recently oxidative stress has been proposed as the cause of hypertension. An imbalance in superoxide and nitric oxide production may account for reduced vasodilation, which in turn can favor the development of hypetension. In vitro and in human studies support this hypothesis. The supplementation of antioxidants, particularly in the form of fresh fruit and vegetables, reduces blood pressure, supporting a role for free radicals in hypertension.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > RB Pathology R Medicine > RC Internal medicine |
||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||
Library of Congress Subject Headings (LCSH): | Oxidative stress, Hypertension -- Etiology | ||||
Journal or Publication Title: | Diabetes Care | ||||
Publisher: | American Diabetes Association | ||||
ISSN: | 0149-5992 | ||||
Official Date: | February 2008 | ||||
Dates: |
|
||||
Volume: | Vol.31 | ||||
Number: | Suppl.2 | ||||
Number of Pages: | 4 | ||||
Page Range: | S181-S184 | ||||
DOI: | 10.2337/dc08-s245 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access | ||||
Description: | Based on a presentation at: 1st Meeting on Controversies in Obesity, Diabetes and Hypertension, Berlin, Germany, Oct, 2006 |
||||
Funder: | Merck Sharp & Dohme, Produits Roche S.A., Sanofi aventis (Firm), Novo Nordisk, Medtronic, Inc., Lifescan Inc., World Wide, Eli Lilly and Company, Keryx, Abbott Laboratories, Novartis (Firm), Pfizer Inc., Generx Biotechnology, Schering-Plough Corporation, Johnson & Johnson | ||||
Type of Event: | Conference |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |